Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03557918
Title Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Matthew Galsky
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.